Karim Boussebaa - Align Technology Executive Business
| ALGN Stock | USD 232.77 3.11 1.35% |
Executive
Karim Boussebaa is Executive Business of Align Technology
| Address | 410 North Scottsdale Road, Tempe, AZ, United States, 85288 |
| Phone | 602 742 2000 |
| Web | https://www.aligntech.com |
Align Technology Management Efficiency
The company has return on total asset (ROA) of 0.067 % which means that it generated a profit of $0.067 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.114 %, meaning that it created $0.114 on every $100 dollars invested by stockholders. Align Technology's management efficiency ratios could be used to measure how well Align Technology manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Align Technology's Return On Tangible Assets are very stable compared to the past year. As of the 2nd of December 2024, Return On Capital Employed is likely to grow to 0.17, while Return On Equity is likely to drop 0.09. At this time, Align Technology's Intangible Assets are very stable compared to the past year. As of the 2nd of December 2024, Net Tangible Assets is likely to grow to about 3.7 B, while Deferred Long Term Asset Charges is likely to drop about 52.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Dragana Bunjevac | Stryker | N/A | |
| Tim Benner | Inari Medical | N/A | |
| Nick Corcoran | TransMedics Group | 42 | |
| Mary Moynihan | Boston Scientific Corp | 57 | |
| Melissa Mann | Inspire Medical Systems | N/A | |
| Dirksen Lehman | Edwards Lifesciences Corp | N/A | |
| Stuart Silk | Stryker | N/A | |
| Angela JD | Inari Medical | N/A | |
| Sadie Stern | DexCom Inc | 49 | |
| Matthew Dolan | DexCom Inc | 43 | |
| Angela Wiczek | Insulet | N/A | |
| Leverne Marsh | DexCom Inc | N/A | |
| MPH MD | Medtronic PLC | N/A | |
| Shacey Petrovic | Insulet | 51 | |
| Trang Ly | Insulet | N/A | |
| Torod Neptune | Medtronic PLC | N/A | |
| Gregory Smith | Medtronic PLC | 60 | |
| Robert Hopkins | Medtronic PLC | N/A | |
| Sabina Ewing | Abbott Laboratories | 50 | |
| June Lazaroff | Insulet | N/A | |
| MD FSIR | Penumbra | N/A | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.067 |
Align Technology Leadership Team
Elected by the shareholders, the Align Technology's board of directors comprises two types of representatives: Align Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Align. The board's role is to monitor Align Technology's management team and ensure that shareholders' interests are well served. Align Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Align Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emory Wright, Executive Operations | ||
| Sreelakshmi Kolli, Vice President - Information Technology | ||
| Simon Beard, Vice President Managing Director - EMEA | ||
| Zelko Relic, Vice President - Research and Development | ||
| Shirley Stacy, IR Contact Officer | ||
| Julie JD, Executive Officer | ||
| Joseph Hogan, CEO and President and Director | ||
| Mitra Derakhshan, Executive Officer | ||
| Vamsi Pudipeddi, Executive Officer | ||
| Jennifer OlsonWilk, Executive Success | ||
| Karim Boussebaa, Executive Business | ||
| John Morici, CFO Finance | ||
| Stuart Hockridge, Vice President - Global Human Resources | ||
| David Carr, EVP region | ||
| Julie Coletti, Executive Officer | ||
| Srini Kaza, Executive Development |
Align Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Align Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.067 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 16.46 B | ||||
| Shares Outstanding | 74.65 M | ||||
| Shares Owned By Insiders | 6.60 % | ||||
| Shares Owned By Institutions | 89.70 % | ||||
| Number Of Shares Shorted | 3 M | ||||
| Price To Earning | 29.97 X |
Pair Trading with Align Technology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Align Technology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Align Technology will appreciate offsetting losses from the drop in the long position's value.Moving against Align Stock
| 0.58 | ECOR | Electrocore LLC | PairCorr |
| 0.48 | MD | Mednax Inc | PairCorr |
| 0.45 | EUDA | EUDA Health Holdings | PairCorr |
| 0.42 | ABT | Abbott Laboratories Sell-off Trend | PairCorr |
| 0.33 | FEMY | Femasys | PairCorr |
The ability to find closely correlated positions to Align Technology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Align Technology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Align Technology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Align Technology to buy it.
The correlation of Align Technology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Align Technology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Align Technology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Align Technology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Align Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Align Stock, please use our How to Invest in Align Technology guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Align Technology. If investors know Align will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Align Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.02) | Earnings Share 5.87 | Revenue Per Share 52.669 | Quarterly Revenue Growth 0.018 | Return On Assets 0.067 |
The market value of Align Technology is measured differently than its book value, which is the value of Align that is recorded on the company's balance sheet. Investors also form their own opinion of Align Technology's value that differs from its market value or its book value, called intrinsic value, which is Align Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Align Technology's market value can be influenced by many factors that don't directly affect Align Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Align Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Align Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Align Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.